Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM
Status:
Completed
Trial end date:
2020-08-12
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and aafety of rosuvastatin/ezetimibe combination
therapy vs. rosuvastatin monotherapy in atherosclerotic cardiovascular disease patients with
type 2 diabetes mellitus